id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-343870-g2v7ihud	Liu, Wei	Virus-, host-, immune-based targets for COVID-19 therapy	2020-10-06		.txt	text/plain	1716	102	46	Anti-viral agents against different targets had exhibited profound therapeutic effect on SARS-CoV-2 through which the clinicians were able to control the COVID-19 outbreak. Clinicians worldwide have been voraciously seeking for a potential anti-COVID-19 drug of all modules such as vaccines; targetspecific monoclonal antibodies; viral oligonucleotide-based peptide drugs; interferons and other small bio-actives [2] . S protein being the crucial protein facilitating the SARS-CoV-2 entry into the host has been preferred as a potential therapeutic target of interests as it could be spliced into two individual peptides by the furin-like proteases [5] . The other novel drug-like K22 that inhibits the viral-dependent RNA synthesis exhibited strong anti-replicative activity against the coronaviruses in an in-vitro set-up. Stimulation of innate immune response is crucial for controlling the SARS-CoV-2 replication and its virulence on the infected hosts [8] .	./cache/cord-343870-g2v7ihud.txt	./txt/cord-343870-g2v7ihud.txt